vimarsana.com

Latest Breaking News On - கேம்பிரிட்ஜ் கெஂடெல் சதுரம் - Page 2 : vimarsana.com

Township Capital s Industrial Portfolio Deepens with Acquisition of 67,000 Square-Foot Industrial Property in Booming Cambridge, MA

Township Capital s Industrial Portfolio Deepens with Acquisition of 67,000 Square-Foot Industrial Property in Booming Cambridge, MA
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

Sox Owners Embrace Fenway Grit in 2 1M SF Development

Select Page Sox Owners Embrace Fenway ‘Grit’ in 2.1M SF Development By Steve Adams | Banker & Tradesman Staff | Jun 3, 2021 | Reprints | Print Image courtesy of Sasaki The Boston Red Sox owners’ game plan for redeveloping 5 acres surrounding Fenway Park contains a heavy emphasis on office and lab space that could bring 10,000 jobs to the neighborhood which is emerging as a new life science hub. Fenway Sports Group proposes 2.1 million square feet of development replacing low-rise buildings and parking lots and garage space, including nearly 1.7 million square feet of office and research space, 216 residential units and 212,000 square feet of retail space. “The area around Fenway Park has a grit and authenticity of place… which should be embraced rather than erased,” the development team stated in a project notification submitted to the Boston Planning & Development Agency.

Moderna will double the size of its Norwood plant

The Cambridge-based biotech is expanding its manufacturing facility to 650,000 square feet and plans to increase production of its COVID-19 vaccine by 50 percent.

Company tied to ALS breakthrough at UMass Medical School wins FDA investigational drug acceptance

By Grant Welker A firm making gene therapy for rare diseases that was co-founded by a UMass Medical School professor has won regulatory approval to continue research and investigatory work for an ALS therapy. Apic Bio, now based in Cambridge s Kendall Square, was co-founded by Dr. Robert Brown Jr., a professor in UMass neurology department. Brown was a lead member of the team that discovered a particular enzyme as the first genetic mutation linked to ALS, or amyotrophic lateral sclerosis. The new therapy whose investigational new drug application was approved by the U.S. Food and Drug Administration began nearly 30 years ago with the gene therapy research conducted by Brown and others. The therapy, whose approval Apic Bio announced April 21, is aimed at slowing or reversing the progression of ALS, a disease also known as Lou Gehrig s disease with no cure and whose cause is unknown.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.